Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

ANCA-Associated Vasculitis in Systemic Sclerosis

Carmen Busca Arenzana, MR, Ander Mayor-Ibarguren, MR, Amara Pieren-Salazar, MR, Natalia Martin-Suñe, MD, Isabel Esteban-Rodríguez, MD, Juan José Ríos-Blanco, MD, & Francisco Arnalich-Fernández, MD  |  Issue: October 2014  |  October 1, 2014

She improved progressively and currently has no peripheral neuropathy or myopathy. Her pulmonary involvement has been stable. However, over time, there has been more extensive cutaneous sclerosis and the development of more digital ulcers.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE
A large, well-demarcated ulcer along the medial malleolar area is shown in a patient with systemic sclerosis. Such ulcers are associated with small-vessel vasculitis.
A large, well-demarcated ulcer along the medial malleolar area is shown in a patient with systemic sclerosis. Such ulcers are associated with small-vessel vasculitis.

Discussion

The development of vasculitis in patients with SS is highly uncommon.1 Whereas the histopathology of SS vasculopathy demonstrates a myofibroblast proliferation and matrix deposition in the subendothelial layer leading to occlusion, the histopathology of vasculitis is characterized by the presence of mononuclear infiltrates and destruction of the vessel wall.

A recent publication by the French Vasculitis Study Group identified nine patients with SS and vasculitis.2 Another study described the characteristics of a series of 40 patients with SS and associated systemic vasculitis, finding that the main clinical manifestation was a rapidly progressive glomerulonephritis (83%), followed by alveolar hemorrhage (28%), limb ischemia (13%) and skin vasculitis (10%).3

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

The presence of a positive ANCA in patients with SS is estimated to be in the range of 7–13%, but its clinical relevance is unknown. MPO-ANCA is more frequent than PR3-ANCA in patients with SS.4

Conclusion

The patient improved after immunosuppressive therapy. She has not experienced a new outbreak of vasculitis, although her cutaneous disease related to scleroderma has progressed.


Carmen Busca Arenzana is a medical resident in the internal medicine department of the Hospital La Paz in Madrid, Spain.
Ander Mayor-Ibarguren is a medical resident in the dermatology department of the Hospital La Paz in Madrid, Spain.
Amara Pieren-Salazar is a medical resident in the rheumatology department of the Hospital La Paz in Madrid, Spain.
Natalia Martin-Suñe, MD, works in the internal medicine department of the Hospital La Paz in Madrid, Spain.
Isabel Esteban-Rodríguez, MD, works in the pathology department of the Hospital La Paz in Madrid. Spain.
Juan José Ríos-Blanco, MD, works in the internal medicine department of the Hospital La Paz in Madrid, Spain.
Francisco Arnalich-Fernandez, MD, works in the internal medicine department of the Hospital La Paz in Madrid, Spain.

References

  1. Quéméneur T, Mouthon L, Cacoub P, et al. Systemic vasculitis during the course of systemic sclerosis. Medicine (Baltimore). 2013 Jan;92(1):1–9.
  2. Arad U, Balbir-Gurman A, Doenyas-Barak K, et al. Anti-neutrophil associated vasculitis in systemic sclerosis. Semin Arthritis Rheum. 2011 Oct;41(2):223–229.
  3. Rho YH, Choi SJ, Lee YH, et al. Scleroderma associated with ANCA-associated vasculitis. Rheumatol Int. 2006 Mar;26(5):369–375.
  4. Mouthon L, Millet A, Régent A, et al. Physiopathologie des vascularites ANCA-positives. Presse Med. 2012 Oct;41(10):996–1003.

Acknowledgments: The authors would like to thank Martin J. Smyth for his help in correcting their English.

Page: 1 2 3 | Single Page
Share: 

Filed under:ConditionsSystemic Sclerosis Tagged with:ANCA-Associated Vasculitisdrugpatient careprednisoneRaynaud'srheumatologistSclerodermaSystemic sclerosisTreatmentVasculitis

Related Articles

    New Tools for Myositis Diagnosis, Classification & Management

    April 15, 2019

    CHICAGO—At Hot Topics in Myositis, a session at the 2018 ACR/ARHP Annual Meeting, three experts discussed new classification criteria for idiopathic inflammatory myopathies (IIM) and offered practical primers on overlap myositis conditions and inclusion body myositis (IBM). New Myositis Classification Criteria After a 10-year development process, the new EULAR/ACR Classification Criteria for Adult and Juvenile…

    Case Report: Hydralazine-Induced ANCA-Associated Vasculitis

    February 16, 2021

    Hydralazine has been in use as a treatment for hypertension, most notably in heart failure patients, since 1951.1 The drug is a known cause of autoimmune disease, most specifically hydralazine-induced lupus.  Hydralazine-induced lupus occurs in 7–13% of those taking the medication.2-4 It often presents with constitutional symptoms, arthritis/arthralgias, cutaneous lesions, sero­sitis, myalgias and/or hepatomegaly. Features…

    Lost and found

    The History of ACE Inhibitors in Scleroderma Renal Crisis

    February 16, 2021

    Scleroderma renal crisis is a true medical emergency in rheumatology, one that requires prompt diagnosis and treatment. Here, we review the historic introduction of the angiotensin-converting enzyme inhibitors in this context, and highlight management and key questions moving forward. Background Awareness of renal disease in scleroderma dates back many years. The revered physician William Osler…

    Case Report: Interstitial Lung Disease with Positive ANCA Test

    October 13, 2015

    “Worst of all is the pain in my calves,” she said. “It feels like burning deep inside.” So began my first encounter with a 69-year-old woman who was referred to rheumatology clinic for evaluation of two months of constitutional symptoms and a positive ANCA test, which had been ordered by her primary care doctor. Her…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences